Bone mineral density as a surrogate endpoint for fracture risk reduction in clinical trials of osteoporosis therapies: an update on SABRE
Dennis M. Black, Austin R. Thompson, Richard Eastell, Mary Bouxsein
Topics & Concepts
MedicineSurrogate endpointOsteoporosisReduction (mathematics)Bone mineralClinical trialClinical endpointOsteoporotic fractureInternal medicineIntensive care medicineGeometryMathematicsBone health and osteoporosis researchBone health and treatmentsBone and Joint Diseases